Artal Group S.A. - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 54 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20.0%5520.0%0.00%
Q2 2023$2
-99.8%
552
-100.0%
0.00%
-100.0%
Q1 2023$1,206
-33.8%
2,779,1220.0%0.07%
-29.4%
Q4 2022$1,823
-99.9%
2,779,1220.0%0.10%0.0%
Q3 2022$2,391,000
+56.8%
2,779,1220.0%0.10%
+25.9%
Q2 2022$1,525,000
-50.6%
2,779,1220.0%0.08%
-37.2%
Q1 2022$3,085,000
-35.5%
2,779,1220.0%0.13%
-0.8%
Q4 2021$4,780,000
-44.0%
2,779,1220.0%0.13%
-31.9%
Q3 2021$8,532,000
-21.3%
2,779,1220.0%0.19%
-13.2%
Q2 2021$10,838,000
+113.7%
2,779,122
+52.9%
0.22%
+144.4%
Q1 2021$5,071,000
-8.8%
1,817,5840.0%0.09%
-24.4%
Q4 2020$5,561,000
-49.7%
1,817,5840.0%0.12%
-55.6%
Q3 2020$11,051,000
+1.5%
1,817,584
-1.3%
0.27%
-11.8%
Q2 2020$10,883,000
+120.6%
1,841,584
-1.1%
0.30%
+46.2%
Q1 2020$4,933,000
+33.2%
1,861,584
+36.7%
0.21%
+45.5%
Q4 2019$3,703,000
-77.6%
1,361,5840.0%0.14%
-78.4%
Q3 2019$16,502,000
+5.8%
1,361,5840.0%0.66%
+4.9%
Q2 2019$15,590,0001,361,5840.63%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$3,105,6830.15%
Artal Group S.A. 2,779,122$1,2060.07%
MFN Partners Management, LP 3,389,215$1,470,5800.07%
Intrinsic Value Partners, LLC 43,105$18,7030.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$49,8990.00%
Penobscot Investment Management Company, Inc. 10,000$4,3390.00%
COLONY GROUP LLC 102,884$440.00%
CAPTRUST FINANCIAL ADVISORS 292,645$126,9790.00%
GEODE CAPITAL MANAGEMENT, LLC 592,237$256,9710.00%
STATE STREET CORP 115,414$50,0780.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders